700 patients109,892 observations180 daysLIVE
eligible for NP-02 · confidence ≥ 70%

Patients needing attention

Synthetic demo data
Clear
42
patients · eligible for NP-02 · confidence ≥ 70%
Most common reason
GI intolerance
Most effective previous action
GI-04
Nutritional protocol
Estimated addressable population
19
eligible for GI-04, confidence ≥ 70%
Predicted persistence gain
+17%
LLIFE OS insight · why this cohort goes where it goes
grounded · add an LLM key for prose

eligible for NP-02 · confidence ≥ 70%: 42 patients, mean day 160. 17% have deteriorating tolerance, 88% unstable GI, 98% carry ≥60% discontinuation risk; mean GI 65, adherence 51%. Dominant clusters: EC-03 79%, LT 21%.

Shared biology: Low microbial diversity 83%, Cluster EC-03 (high response / high intolerance) 79%, Low butyrate capacity 74%, FUT2 non-secretor 71%, Adherence < 60% 71%, IL6 high-expression variant 62%, Baseline state S14 62%. Dietary detractors: fat in 98%, ultraProcessed in 83%, simpleCarbs in 79%.

What worked: SC-12 improved 89% of 9; what did not: GI-04 improved only 53% of 15. By biology: SC-12 works best in FUT2 non-secretor (100%) and worst in Low butyrate capacity (80%); GI-04 works best in IL6 high-expression variant (67%) and worst in Low butyrate capacity (50%).

No learned rules apply yet; run learning after the first campaign results.

PatientDayBaselineGIToleranceGI scoreDiscontinuationCluster
P-02028172S16UnstableImproving7796%EC-03
P-02369170S14UnstableUnstable7096%EC-03
P-02524158S14UnstableImproving6696%EC-03
P-02537170S14UnstableDeteriorating7096%EC-03
P-02557175S14UnstableStable7996%EC-03
P-02628170S14UnstableStable6296%EC-03
P-02656168S14UnstableDeteriorating6596%EC-03
P-02667171S14UnstableStable7696%EC-03
P-02692169S14UnstableImproving7096%EC-03
P-02700173S14UnstableImproving6596%EC-03
P-02434177S14UnstableDeteriorating6095%EC-03
P-02472112S14UnstableUnstable6094%EC-03
P-02538168S12UnstableDeteriorating7493%EC-03
P-02586176S14UnstableStable6093%EC-03
P-02053178S01UnstableImproving7592%LT
P-02581172S14ImprovingDeteriorating5692%EC-03
P-02607170S09UnstableStable7692%EC-03
P-02626168S14UnstableImproving6092%EC-03
P-0267294S14UnstableDeteriorating6892%EC-03
P-02654102S14UnstableStable6587%EC-03
P-02014168S14UnstableUnstable7086%EC-03
P-02107180S11UnstableStable6186%EC-03
P-02156155S14DeterioratingStable5584%EC-03
P-02076173S14UnstableUnstable6582%EC-03
P-02202180S14UnstableStable6182%EC-03
P-02480140S14UnstableStable6882%EC-03
P-02211170S11UnstableStable6281%LT
P-02475123S14UnstableImproving7079%EC-03
P-02245180S14UnstableDeteriorating5877%EC-03
P-02568179S20UnstableImproving7276%LT
P-02415173S05UnstableUnstable6675%EC-03
P-02144172S03UnstableImproving6174%EC-03
P-02291101S14DeterioratingFavorable5772%EC-03
P-02368176S14ImprovingStable5271%EC-03
P-0251991S08DeterioratingFavorable3869%LT
P-02162174S15UnstableUnstable6568%LT
P-02300176S20UnstableImproving6468%EC-03
P-02468147S01UnstableImproving7368%EC-03
P-02139177S02UnstableStable6467%LT
P-02113168S02UnstableImproving6466%LT
P-02271170S14UnstableImproving6165%LT
P-02553151S11UnstableStable6358%LT